Understanding how mycobacteria maintain their cell structure
Cell envelope integrity in mycobacteria: interplay of lipoglycans, peptidoglycan, and capsular polysaccharides
This study is looking at certain molecules in the outer layer of tuberculosis bacteria to see how they help the bacteria grow and stay strong, with the hope of finding new ways to treat infections.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Massachusetts Amherst NIH-funded |
| Lab location | 1 site (Hadley, United States) |
| Project ID | NIH-10735899 on NIH RePORTER |
What this research studies
This research investigates the role of specific molecules called lipoglycans in the cell envelope of mycobacteria, particularly focusing on Mycobacterium tuberculosis. The researchers aim to understand how these lipoglycans interact with other components of the cell envelope to maintain its integrity during bacterial growth. By studying these interactions, the research seeks to identify potential weaknesses in the mycobacterial cell envelope that could be targeted for new antimicrobial treatments. This work involves laboratory experiments that analyze the biosynthesis and function of these molecules in both pathogenic and nonpathogenic mycobacteria.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with infections caused by mycobacteria, particularly those with tuberculosis.
Not a fit: Patients with infections caused by non-mycobacterial pathogens or those without active infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antibiotics that specifically target the cell envelope of mycobacteria, improving treatment options for infections like tuberculosis.
How similar studies have performed: Previous research has shown promise in targeting bacterial cell envelope components for antibiotic development, indicating that this approach could be effective.
Where this research is happening
Hadley, United States
- University of Massachusetts Amherst — Hadley, United States (Active)
Researchers
- Principal investigator: Morita, Yasu S — University of Massachusetts Amherst
- Study coordinator: Morita, Yasu S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.